Upgraded CRISPR tool enables more seamless gene editing and improved disease modeling
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...
The Economist29d
CRISPR could yet save millions of lives. Here’s how
Her parents encouraged her to partake in a trial for a CRISPR -based therapy for sickle-cell disease and beta-thalassemia, another debilitating genetic blood disorder. The therapy, Casgevy, was made ...
Mutated DNA Restored to Normal in Gene Therapy Advance
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
2 No-Brainer Biotech Stocks to Buy Right Now
Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...